(Q53921636)

22 May 2018

title

PPARdelta activation induces COX-2 gene expression and cell proliferation in human hepatocellular carcinoma cells. (English)

1 reference

22 May 2018

main subject

hepatocellular carcinoma

1 reference

4

1 reference

22 May 2018

Anders Hamsten

series ordinal

3

object named as

Anders Hamsten

1 reference

22 May 2018

Bjorn Glinghammar

1

1 reference

22 May 2018

Josefin Skogsberg

series ordinal

2

1 reference

22 May 2018

language of work or name

English

0 references

publication date

1 August 2003

1 reference

22 May 2018

Biochemical and Biophysical Research Communications

published in

1 reference

22 May 2018

volume

308

1 reference

22 May 2018

issue

2

1 reference

22 May 2018

page(s)

361-368

1 reference

22 May 2018

Multifactoral etiology of human liver cancer

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

Characterization of the genomic structure, chromosomal location and promoter of human prostaglandin H synthase-2 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

Benzo[a]pyrene up-regulates cyclooxygenase-2 gene expression in oral epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

Differential expression of prostaglandin H synthase isozymes during multistage carcinogenesis in mouse epidermis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

Prostaglandins and breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

Prostaglandins and human lung carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

The production of prostanoids in human cancers, and their implications for tumor progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

Roles of PPARs in health and disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

PPARgamma: an essential regulator of adipogenesis and modulator of fat cell function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. Involvement of both nuclear factor for interleukin-6 expression site and cAMP response element

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

The cyclic AMP response element plays an essential role in the expression of the human prostaglandin-endoperoxide synthase 2 gene in differentiated U937 monocytic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

The peroxisome proliferator-activated receptor delta promotes lipid accumulation in human macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

Effects of colonic lumenal components on AP-1-dependent gene transcription in cultured human colon carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

Absence of nuclear factor kappaB inhibition by NSAIDs in hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

Phenotypic variation in human HepG2 hepatoma cells: alterations in cell growth, plasma protein synthesis and heme pathway enzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

Identification of HepG2 variant cell lines by short tandem repeat (STR) analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

Peroxisome proliferator-activated receptor-beta signaling contributes to enhanced proliferation of hepatic stellate cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

Expression of cyclooxygenase-2 in foetal rat hepatocytes stimulated with lipopolysaccharide and pro-inflammatory cytokines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

Hyperosmolarity stimulates prostaglandin synthesis and cyclooxygenase-2 expression in activated rat liver macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

Induction of cyclooxygenase-2 expression by peroxisome proliferators and non-tetradecanoylphorbol 12,13-myristate-type tumor promoters in immortalized mouse liver cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

Regulation of constitutive cyclooxygenase-2 expression in colon carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

Antiapoptotic role of PPARbeta in keratinocytes via transcriptional control of the Akt1 signaling pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and CREB-binding protein/p300.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

Peroxisome proliferator-activated receptor delta is up-regulated during vascular lesion formation and promotes post-confluent cell proliferation in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

Peroxisome proliferator-activated receptor delta activation promotes cell survival following hypertonic stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901384-6

10.1016/S0006-291X(03)01384-6

7 January 2021

Identifiers

DOI

1 reference

22 May 2018

1 reference

22 May 2018